title: Re: Agrawal et al.: The safety and efficacy of different doses of bacillus Calmette-Guérin in superficial bladder transitional cell carcinoma. (Urology 2007;70:1075-1078).
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Simone
authors.forename: Costantino
authors.initials: C
authors.lastname: Leonardo
authors.forename: Michele
authors.initials: M
authors.lastname: Gallucci
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D001500:BCG Vaccine / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine